Panagora Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.1M Buy
654,194
+435
+0.1% +$9.38K 0.06% 227
2025
Q1
$10.9M Sell
653,759
-1,382
-0.2% -$23K 0.05% 243
2024
Q4
$12M Sell
655,141
-8,031
-1% -$147K 0.06% 225
2024
Q3
$10.2M Buy
663,172
+1,302
+0.2% +$20K 0.05% 237
2024
Q2
$10.8M Sell
661,870
-39,422
-6% -$641K 0.05% 209
2024
Q1
$13M Buy
701,292
+56,372
+9% +$1.04M 0.07% 208
2023
Q4
$20.2M Buy
644,920
+1,922
+0.3% +$60.2K 0.11% 159
2023
Q3
$13.4M Sell
642,998
-32,163
-5% -$670K 0.08% 183
2023
Q2
$16.2M Sell
675,161
-52,840
-7% -$1.27M 0.1% 188
2023
Q1
$13.7M Buy
728,001
+47,396
+7% +$892K 0.09% 210
2022
Q4
$10.8M Buy
680,605
+23,161
+4% +$369K 0.07% 247
2022
Q3
$10.8M Buy
657,444
+10,677
+2% +$175K 0.07% 237
2022
Q2
$9.11M Buy
646,767
+166,885
+35% +$2.35M 0.06% 268
2022
Q1
$11.6M Buy
479,882
+79,264
+20% +$1.92M 0.06% 257
2021
Q4
$9.35M Sell
400,618
-8,408
-2% -$196K 0.05% 303
2021
Q3
$6.79M Buy
409,026
+2,699
+0.7% +$44.8K 0.04% 365
2021
Q2
$9.91M Buy
406,327
+401,731
+8,741% +$9.8M 0.05% 295
2021
Q1
$119K Buy
+4,596
New +$119K ﹤0.01% 1909
2020
Q3
Sell
-3,522
Closed -$171K 2691
2020
Q2
$171K Sell
3,522
-23,984
-87% -$1.16M ﹤0.01% 1598
2020
Q1
$1.16M Buy
+27,506
New +$1.16M 0.01% 795
2016
Q3
Sell
-20,787
Closed -$675K 2407
2016
Q2
$675K Buy
+20,787
New +$675K ﹤0.01% 1264
2015
Q3
Sell
-937
Closed -$39K 2307
2015
Q2
$39K Sell
937
-3,308
-78% -$138K ﹤0.01% 2198
2015
Q1
$138K Buy
4,245
+2,833
+201% +$92.1K ﹤0.01% 1829
2014
Q4
$45K Sell
1,412
-474
-25% -$15.1K ﹤0.01% 2058
2014
Q3
$47K Buy
1,886
+474
+34% +$11.8K ﹤0.01% 2036
2014
Q2
$32K Sell
1,412
-3,481
-71% -$78.9K ﹤0.01% 2176
2014
Q1
$119K Buy
+4,893
New +$119K ﹤0.01% 1889
2013
Q3
Sell
-248,570
Closed -$4.51M 2298
2013
Q2
$4.51M Buy
+248,570
New +$4.51M 0.02% 484